Mini Review
Published on 07 Mar 2024
Experimental evidence for anti-metastatic actions of apigenin: a mini review
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2024.1380194
- 1,891 views
Type at least 3 characters
1,880 articles
Original Research
Published on 07 Mar 2024
Sulforaphane inhibits the growth of prostate cancer by regulating the microRNA-3919/DJ-1 axis
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2024.1361152
- 2,395 views
- 6 citations
Review
Published on 06 Mar 2024
Dark horse target Claudin18.2 opens new battlefield for pancreatic cancer
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2024.1371421
- 8,434 views
- 3 citations
Mini Review
Published on 04 Mar 2024
The TGF-β superfamily as potential therapeutic targets in pancreatic cancer
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2024.1362247
- 3,777 views
- 9 citations
Correction
Published on 29 Feb 2024
Corrigendum: Carnosol, a natural polyphenol, inhibits migration, metastasis, and tumor growth of breast cancer via a ROS-dependent proteasome degradation of STAT3
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2023.1235201
- 1,501 views
- 1 citation
Review
Published on 28 Feb 2024
Expression and prognosis of ADAMTS18 in different tumors
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2024.1347633
- 1,546 views
Editorial
Published on 28 Feb 2024
Editorial: Integrating transcriptional modulation in systemic tumor therapy
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2024.1385766
- 907 views
Systematic Review
Published on 28 Feb 2024
A systematic review and Bayesian meta-analysis assessing intelectin-1 in cancer patients and healthy individuals
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2024.1198555
- 1,612 views
- 1 citation
Review
Published on 26 Feb 2024
Ferroptosis and EMT resistance in cancer: a comprehensive review of the interplay
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2024.1344290
- 5,210 views
- 9 citations
Mini Review
Published on 26 Feb 2024
In vitro and in vivo modeling systems of supratentorial ependymomas
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2024.1360358
- 2,067 views
Original Research
Published on 26 Feb 2024
Oncopig bladder cancer cells recapitulate human bladder cancer treatment responses in vitro
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2024.1323422
- 2,574 views
- 2 citations
Correction
Published on 22 Feb 2024
Corrigendum: ITGB5 promotes innate radiation resistance in pancreatic adenocarcinoma by promoting DNA damage repair and the MEK/ERK signaling pathway
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2024.1381151
- 922 views
Review
Published on 21 Feb 2024
Current treatment strategies targeting histone deacetylase inhibitors in acute lymphocytic leukemia: a systematic review
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2024.1324859
- 2,466 views
- 4 citations
Case Report
Published on 06 Feb 2024
Case report: Response to Savolitinib/EGFR-TKI combination in NSCLC patients harboring concurrent primary MET amplification/overexpression and EGFR mutation
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2024.1297156
- 1,713 views
Original Research
Published on 06 Feb 2024
Selective inhibition of DNA ligase IV provides additional efficacy to the treatment of anaplastic thyroid cancer
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2024.1323313
- 2,775 views
- 1 citation
Original Research
Published on 05 Feb 2024
The prognosis of TP53 and EGFR co-mutation in patients with advanced lung adenocarcinoma and intracranial metastasis treated with EGFR-TKIs
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2023.1288468
- 2,739 views
- 5 citations